Monthly Archives: August, 2023

Browse our exclusive articles!

Federal Government Urged to Build Guardrails for Generative AI Content

Federal Government urged to regulate generative AI content to protect against misuse and false narratives. Learn more about the importance of establishing guardrails for AI technology.

AI Adoption Positively Impacts Sales and Customer Service, Surprising Survey Finds

Discover surprising survey findings on how AI adoption positively impacts sales and customer service, debunking fears of job loss. Read more.

Dynatrace to Acquire Rookout, Enhancing Code-Level Observability and Debugging for Developers

Dynatrace to acquire Rookout, empowering developers with code-level observability and debugging in production. Enhance innovation with flawless and secure releases.

Grammarly Co-founder: No Immediate Plans for IPO Despite $13B Valuation

Grammarly, the Canadian and Ukrainian AI firm renowned for its AI-powered writing assistance software, currently has no plans for an IPO despite its $13 billion valuation. Discover why Grammarly prefers to focus on innovation and writing solutions.

DoorDash Boosts Earnings Forecast as New Verticals Thrive and User Growth Accelerates

DoorDash raises earnings forecast as new verticals and user growth drive success. Analysts anticipate positive results. Read more.

Popular

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.

Pioneering Research Uncovers Vital Biomarker for Orbital Inflammation

An in-depth study reveals HLF as a potential biomarker for orbital inflammation, offering new insights for diagnosis and treatment strategies.

Subscribe

spot_imgspot_img